This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, M R
Right arrow Articles by Lowy, D R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, M R
Right arrow Articles by Lowy, D R

 Previous Article  |  Next Article 

Mol Cell Biol. 1994 January; 14(1): 641-645

Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.

M R Johnson, J E DeClue, S Felzmann, W C Vass, G Xu, R White and D R Lowy

Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

The NF1 gene, which is altered in patients with type 1 neurofibromatosis, has been postulated to function as a tumor suppressor gene. The NF1 protein product neurofibromin stimulates the intrinsic GTPase activity of active GTP-bound Ras, thereby inactivating it. Consistent with a tumor suppressor function, we have found that the introduction of NF1 in melanoma cell lines that are deficient in neurofibromin inhibited their growth and induced their differentiation. In addition, overexpression of neurofibromin in NIH 3T3 cells was growth inhibitory but did not alter the level of GTP.Ras in the cells. Transformation by v-ras, whose protein product is resistant to GTPase stimulation by neurofibromin, was inhibited in a cell line overexpressing neurofibromin, while transformation by v-raf was not altered. The results demonstrate that NF1 is a tumor suppressor gene that can inhibit Ras-dependent growth by a regulatory mechanism that is independent of neurofibromin's ability to stimulate Ras GTPase.

Mol Cell Biol. 1994 January; 14(1): 641-645




This article has been cited by other articles:

  • Maki, R. G., D'Adamo, D. R., Keohan, M. L., Saulle, M., Schuetze, S. M., Undevia, S. D., Livingston, M. B., Cooney, M. M., Hensley, M. L., Mita, M. M., Takimoto, C. H., Kraft, A. S., Elias, A. D., Brockstein, B., Blachere, N. E., Edgar, M. A., Schwartz, L. H., Qin, L.-X., Antonescu, C. R., Schwartz, G. K. (2009). Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas. JCO 27: 3133-3140 [Abstract] [Full Text]  
  • Diwakar, G., Zhang, D., Jiang, S., Hornyak, T. J. (2008). Neurofibromin as a regulator of melanocyte development and differentiation. J. Cell Sci. 121: 167-177 [Abstract] [Full Text]  
  • Bennett, M. R., Rizvi, T. A., Karyala, S., McKinnon, R. D., Ratner, N. (2003). Aberrant Growth and Differentiation of Oligodendrocyte Progenitors in Neurofibromatosis Type 1 Mutants. J. Neurosci. 23: 7207-7217 [Abstract] [Full Text]  
  • Zhu, Y., Romero, M. I., Ghosh, P., Ye, Z., Charnay, P., Rushing, E. J., Marth, J. D., Parada, L. F. (2001). Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 15: 859-876 [Abstract] [Full Text]  
  • Prakash, S. K., Paylor, R., Jenna, S., Lamarche-Vane, N., Armstrong, D. L., Xu, B., Mancini, M. A., Zoghbi, H. Y. (2000). Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoA. Hum Mol Genet 9: 477-488 [Abstract] [Full Text]  
  • Aaltonen, V., Bostrom, P. J., Soderstrom, K.-O., Hirvonen, O., Tuukkanen, J., Nurmi, M., Laato, M., Peltonen, J. (1999). Urinary Bladder Transitional Cell Carcinogenesis Is Associated with Down-Regulation of NF1 Tumor Suppressor Gene in Vivo and in Vitro. Am. J. Pathol. 154: 755-765 [Abstract] [Full Text]  
  • Klesse, L. J., Parada, L. F. (1998). p21 Ras and Phosphatidylinositol-3 Kinase Are Required for Survival of Wild-Type and NF1 Mutant Sensory Neurons. J. Neurosci. 18: 10420-10428 [Abstract] [Full Text]  
  • Rosenbaum, T., Patrie, K. M., Ratner, N. (1997). Neurofibromatosis Type 1: Genetic and Cellular Mechanisms of Peripheral Nerve Tumor Formation. Neuroscientist 3: 412-420 [Abstract]  
  • Mori, S., Satoh, T., Koide, H., Nakafuku, M., Villafranca, E., Kaziro, Y. (1995). Inhibition of Ras/Raf Interaction by Anti-oncogenic Mutants of Neurofibromin, the Neurofibromatosis Type 1 (NF1) Gene Product, in Cell-free Systems. J. Biol. Chem. 270: 28834-28838 [Abstract] [Full Text]  
  • Wienecke, R., König, A., DeClue, J. E. (1995). Identification of Tuberin, the Tuberous Sclerosis-2 Product. J. Biol. Chem. 270: 16409-16414 [Abstract] [Full Text]  
  • Rosenbaum, T, Boissy, Y., Kombrinck, K, Brannan, C., Jenkins, N., Copeland, N., Ratner, N (1995). Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. Development 121: 3583-3592 [Abstract]  
  • Sherman, L. S., Atit, R., Rosenbaum, T., Cox, A. D., Ratner, N. (2000). Single Cell Ras-GTP Analysis Reveals Altered Ras Activity in a Subpopulation of Neurofibroma Schwann Cells but Not Fibroblasts. J. Biol. Chem. 275: 30740-30745 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»